Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Oct 20, 2022

Accession no.
0001209191-22-054157
Filed
Oct 20, 2022, 6:24 AM ET
Trade date
Oct 19, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market purchases total $172.1K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 19, 2022Common StockPPurchaseAcquired+11,188$1.70+$18,963.66198,142,882Indirect
Oct 19, 2022Common StockPPurchaseAcquired+30,000$1.70+$51,000198,172,882Indirect
Oct 19, 2022Common StockPPurchaseAcquired+480$1.71+$818.4198,173,362Indirect
Oct 19, 2022Common StockPPurchaseAcquired+6,900$1.71+$11,799198,180,262Indirect
Oct 19, 2022Common StockPPurchaseAcquired+700$1.74+$1,214.5198,180,962Indirect
Oct 19, 2022Common StockPPurchaseAcquired+50,732$1.74+$88,273.68198,231,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)